HIF1A and pulmonary arterial hypertension: Many studies have shown that DNA methylation, which epigenetically silences SOD2, especially in PAH patients, leads to a reduction in H2O2 production and activation of HIF-1α [30], thereby destroying mitochondrial metabolism and dynamics, increasing aerobic glycolysis, and resulting in accelerated PASMC proliferation and inhibited apoptosis [26].